1. A consensus report on appropriate treatment optimization and transitioning in the management of moderate‐to‐severe plaque psoriasis. (26th February 2013) Authors: Mrowietz, U.; de Jong, E.M.G.J.; Kragballe, K.; Langley, R.; Nast, A.; Puig, L.; Reich, K.; Schmitt, J.; Warren, R.B. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 4(2014:Apr.) Page Start: 438 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A European subset analysis from the population‐based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country‐specific features: results from psoriasis patients in Spain. (25th April 2017) Authors: Puig, L.; van de Kerkhof, P.C.M.; Reich, K.; Bachelez, H.; Barker, J.; Girolomoni, G.; Paul, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 7(2017) Page Start: 1176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A study of the drug tildrakizumab in psoriasis patients. (1st March 2020) Authors: Reich, K.; Warren, R.B.; Iversen, L.; Puig, L.; Pau‐Charles, I.; Igarashi, A.; Ohtsuki, M.; Falqués, M.; Harmut, M.; Rozzo, S.; Lebwohl, M.G.; Cantrell, W.; Blauvelt, A.; Thaçi, D. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A study of the drug tildrakizumab in psoriasis patients. (28th February 2020) Authors: Reich, K.; Warren, R.B.; Iversen, L.; Puig, L.; Pau‐Charles, I.; Igarashi, A.; Ohtsuki, M.; Falqués, M.; Harmut, M.; Rozzo, S.; Lebwohl, M.G.; Cantrell, W.; Blauvelt, A.; Thaçi, D. Journal: British journal of dermatology Issue: Volume 182:Number 3(2020) Page Start: e100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64‐week multinational randomized phase IV study in 1790 patients (PSO‐TOP). (1st July 2017) Authors: Reich, K.; Zschocke, I.; Bachelez, H.; de Jong, E.M.G.J.; Gisondi, P.; Puig, L.; Warren, R.B.; Ortland, C.; Mrowietz, U. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64‐week multinational randomized phase IV study in 1790 patients (PSO‐TOP). (6th June 2017) Authors: Reich, K.; Zschocke, I.; Bachelez, H.; de Jong, E.M.G.J.; Gisondi, P.; Puig, L.; Warren, R.B.; Ortland, C.; Mrowietz, U. Journal: British journal of dermatology Issue: Volume 177:Number 1(2017) Page Start: 197 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0017 Association study of genetic risk variants for psoriasis in a large cohort of psoriatic arthritis, psoriasis and controls of the spanish population and association with relevant clinical subphenotypes. (23rd January 2014) Authors: Cañete, J.D.; Hernanz, J.M.; Fonseca, E.; Ferrandiz, C.; Unamuno, P.; Puig, L.; Fernandez-Sueiro, J.L.; Sanmartí, R.; Rodriguez, J.; Gratacόs, J.; Dauden, E.; Sánchez-Carazo, J.L.; Lόpez-Estebaranz, J.L.; Moreno, D.; Queirό, R.; Ferrandiz, C.; Torre-Alonso, J.C.; Pérez-Venegas, J.J.; Vanaclocha, ... Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 638 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. AB0747 Early and Sustained Modified PSARC Response in Psoriatic Arthritis Patients Treated with Ustekinumab: Results from PSUMMIT 1 and PSUMMIT 2. (10th June 2014) Authors: McInnes, I.; Ritchlin, C.; Rahman, P.; Puig, L.; Gottlieb, A.B.; Song, M.; Randazzo, B.; Li, S.; Wang, Y.; Mendelsohn, A.; Kavanaugh, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Actinic keratosis with atypical basal cells (AK I) is the most common lesion associated with invasive squamous cell carcinoma of the skin. (26th November 2014) Authors: Fernández‐Figueras, M.T.; Carrato, C.; Sáenz, X.; Puig, L.; Musulen, E.; Ferrándiz, C.; Ariza, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 29:Number 5(2015:May) Page Start: 991 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre. (31st October 2013) Authors: López‐Ferrer, A.; Vilarrasa, E.; Gich, I.J.; Puig, L. Journal: British journal of dermatology Issue: Volume 169:Number 5(2013:Nov.) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗